Di Lascio G, Salvini S
Divisione di Medicina, Ospedale Civile Polispecializzato di Anzio.
Clin Ter. 1993 Feb;142(2):123-6.
Fifty patients of either sex with acute and chronic cerebrovascular disorders were submitted to an observation protocol and treated with oral nimodipine (tablets or drops) at a daily dosage of 90 mg for 1 to 3 months. Nimodipine proved useful both from the therapeutic point of view and for its easy handling in acute pathology (TIA, RIND, minor stroke, complete stroke) as well as chronic cerebral ischemia. The drug was well tolerated both locally and systemically; in patients with concomitant arterial hypertension, nimodipine reduced blood pressure with a tendency towards stabilization at near-normal levels.
五十名患有急慢性脑血管疾病的男女患者接受了一项观察方案，并接受口服尼莫地平（片剂或滴剂）治疗，每日剂量为90毫克，持续1至3个月。从治疗角度以及在急性病变（短暂性脑缺血发作、可逆性缺血性神经功能缺损、轻度中风、完全性中风）和慢性脑缺血中易于使用来看，尼莫地平都被证明是有用的。该药物在局部和全身都具有良好的耐受性；在伴有动脉高血压的患者中，尼莫地平降低了血压，并倾向于稳定在接近正常水平。
